van Prooijen HC - Search Results

1

Leukocyte depletion of random single-donor platelet transfusions does not prevent secondary human leukocyte antigen-alloimmunization and refractoriness: a randomized prospective study.

Sintnicolaas K, van Marwijk Kooij M, van Prooijen HC, van Dijk BA, van Putten WL, Claas FH, Novotny VM, Brand A. Sintnicolaas K, et al. Among authors: van prooijen hc. Blood. 1995 Feb 1;85(3):824-8. Blood. 1995. PMID: 7833483 Free article. Clinical Trial.

2

Prevention of MHC-alloimmunization by UV-B irradiation in a murine model: effects of UV dose and number of transfused cells.

Grijzenhout MA, Aarts-Riemens MI, Claas FH, van Prooijen HC. Grijzenhout MA, et al. Among authors: van prooijen hc. Br J Haematol. 1994 Jul;87(3):598-604. doi: 10.1111/j.1365-2141.1994.tb08319.x. Br J Haematol. 1994. PMID: 7993802

3

Use of leukocyte-depleted platelet concentrates for the prevention of refractoriness and primary HLA alloimmunization: a prospective, randomized trial.

van Marwijk Kooy M, van Prooijen HC, Moes M, Bosma-Stants I, Akkerman JW. van Marwijk Kooy M, et al. Among authors: van prooijen hc. Blood. 1991 Jan 1;77(1):201-5. Blood. 1991. PMID: 1984797 Free article. Clinical Trial.

4

[Prevention of HLA alloimmunization due to platelet transfusion].

van Marwijk Kooy M, Brand A, Sintnicolaas K, van Prooijen HC. van Marwijk Kooy M, et al. Among authors: van prooijen hc. Ned Tijdschr Geneeskd. 1988 Apr 23;132(17):758-61. Ned Tijdschr Geneeskd. 1988. PMID: 3374659 Dutch. No abstract available.

5

UVB irradiation of human platelet concentrates does not prevent HLA alloimmunization in recipients.

Grijzenhout MA, Aarts-Riemens MI, de Gruijl FR, van Weelden H, van Prooijen HC. Grijzenhout MA, et al. Among authors: van prooijen hc. Blood. 1994 Nov 15;84(10):3524-31. Blood. 1994. PMID: 7949107 Free article. Clinical Trial.

6

Clinical experience with transfusion of leukocyte-poor platelet concentrates prepared by filtration with prostacyclin.

van Prooijen HC, Riemens TI, Akkerman JW. van Prooijen HC, et al. Blood. 1987 Jul;70(1):243-6. Blood. 1987. PMID: 3297202 Free article.

7

Prevention of donor-specific T-cell unresponsiveness after buffy-coat-depleted blood transfusion.

van Prooijen HC, Aarts-Riemens MI, van Oostendorp WR, Hené RJ, Gmelig-Meyling FH, de Weger RA. van Prooijen HC, et al. Br J Haematol. 1995 Sep;91(1):219-23. doi: 10.1111/j.1365-2141.1995.tb05273.x. Br J Haematol. 1995. PMID: 7577637

8

Reactions and platelet increments after transfusion of platelet concentrates in plasma or an additive solution: a prospective, randomized study.

de Wildt-Eggen J, Nauta S, Schrijver JG, van Marwijk Kooy M, Bins M, van Prooijen HC. de Wildt-Eggen J, et al. Among authors: van prooijen hc. Transfusion. 2000 Apr;40(4):398-403. doi: 10.1046/j.1537-2995.2000.40040398.x. Transfusion. 2000. PMID: 10773049 Clinical Trial.

9

Filtration. A method to prepare white cell-poor platelet concentrates with optimal preservation of platelet viability.

van Marwijk Kooy M, van Prooijen HC, Borghuis L, Moes M, Akkerman JW. van Marwijk Kooy M, et al. Among authors: van prooijen hc. Transfusion. 1990 Jan;30(1):34-8. doi: 10.1046/j.1537-2995.1990.30190117626.x. Transfusion. 1990. PMID: 2296787

10

Prevention of primary transfusion-associated cytomegalovirus infection in bone marrow transplant recipients by the removal of white cells from blood components with high-affinity filters.

van Prooijen HC, Visser JJ, van Oostendorp WR, de Gast GC, Verdonck LF. van Prooijen HC, et al. Br J Haematol. 1994 May;87(1):144-7. doi: 10.1111/j.1365-2141.1994.tb04884.x. Br J Haematol. 1994. PMID: 7947238

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters